Welcome to our dedicated page for Datchat SEC filings (Ticker: DATSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The DATSW SEC filings page on Stock Titan provides access to regulatory documents related to DatChat, Inc.’s Series A warrants and the underlying company, which later changed its name to Myseum, Inc. In these filings, DatChat, Inc. is identified as a Nevada corporation with common stock and Series A warrants registered on the Nasdaq Capital Market under the symbols DATS and DATSW. The warrants are described as each exercisable for one share of common stock at a specified exercise price.
Form 8-K reports linked to DATSW include disclosures about corporate governance and shareholder actions, such as the results of annual meetings, director elections, ratification of the independent registered public accounting firm, and amendments to the company’s 2021 Omnibus Equity Incentive Plan. Other 8-K filings describe corporate events like the granting of a Canadian patent titled “Systems And Methods Of Transforming Electronic Content,” the filing of a registration statement on Form S-1 by former subsidiary RPM Interactive, and the name change from DatChat, Inc. to Myseum, Inc.
Filings also document that, in connection with the name change, the trading symbols for the company’s common stock and Series A warrants were scheduled to change on the Nasdaq Capital Market to “MYSE” and “MYSEW,” respectively, on a specified date. The company stated that these changes did not affect stockholder rights and that no action was required by stockholders.
On this page, users can review how DatChat describes its business as a secure messaging, metaverse, blockchain, cybersecurity, and social media company, as well as how it characterizes the DATSW Series A warrants in the context of its capital structure. Stock Titan’s interface can pair these filings with AI-powered summaries that explain key items, such as warrant terms, equity plan amendments, and significant corporate events, helping readers quickly understand the implications of each document.
Myseum, Inc. director and CEO Darin Myman reported purchases of common stock on 09/03/2025. He acquired 400 shares at $1.935 and 2,600 shares at $1.9499, bringing his direct beneficial ownership to 190,516 shares. The filing also notes indirect ownership attributed to his spouse. The filing contains a standard disclaimer that the reporting person disclaims beneficial ownership of the securities and a signature dated 09/03/2025.
Myseum, Inc. (MYSE) insider purchase reported. Director and Chief Executive Officer Darin Myman acquired 3,000 shares of Myseum common stock on 09/02/2025 at a price of $1.99 per share. After this transaction Mr. Myman directly beneficially owns 187,516 shares. The filing also discloses indirect beneficial ownership attributed to his spouse. The report includes a standard disclaimer that the reporting person disclaims beneficial ownership of certain securities.
Myseum, Inc. (MYSE) director and chief executive officer Darin Myman reported a series of open-market purchases of common stock on 08/28/2025. The report lists four purchase transactions: 400 shares at $2.00, 600 shares at $2.07, 500 shares at $2.05, and 500 shares at $2.65, increasing his direct beneficial ownership from prior holdings to 184,516 shares. The filing also discloses indirect beneficial ownership through a spouse under Rule 23(1). The report includes a standard disclaimer that the reporting person disclaims beneficial ownership of the securities.
Wayne Linsley, a director of Myseum, Inc. (MYSE), was granted options to purchase 5,000 shares of the company's common stock on August 18, 2025. The options have a stated exercise price of $3 and an expiration date of August 18, 2030. According to the filing, the options vest in four equal semiannual installments with the first installment vesting six months after issuance, and the reporting person beneficially owns 5,000 underlying shares following the grant.
Myseum, Inc. (MYSE) reported that director Peter Shelus was granted options to buy 25,000 shares of the company's common stock on 08/18/2025 under the Amended and Restated 2021 Equity Incentive Plan. The options have an exercise price of $3 per share, vest in four equal semiannual installments with the first vesting six months after issuance, and expire on 08/18/2030. Following the grant, the reporting person beneficially owns 25,000 options directly. The Form 4 was signed on 08/19/2025.
Joseph Eugene Nelson, a director of Myseum, Inc. (MYSE), was granted options to purchase 5,000 shares of the company's common stock on 08/18/2025. The options have an exercise price of $3 per share and expire on 08/18/2030. They vest in four equal installments semiannually, with the first installment vesting six months after issuance. Following the grant, the reporting person beneficially owns 5,000 underlying shares on a direct basis. The Form 4 was signed by the reporting person on 08/19/2025. The filing lists the reporting person’s mailing address as C/O Myseum, Inc., 65 Church Street, Suite 230, New Brunswick, NJ 08901.
Darin Myman, CEO and Director of Myseum, Inc. (MYSE), reported multiple open-market purchases of common stock and a grant of stock options. The Form 4 shows three purchases on August 18, 2025 totaling 6,116 shares acquired at prices of $1.93, $1.9132 and $2.15, bringing his direct beneficial ownership to 182,516 shares after the transactions. On the same date he was granted options to purchase 225,000 shares at an exercise price of $3.00 that vest in four equal semiannual installments beginning six months after issuance and expire August 18, 2030. The filing notes indirect beneficial ownership of shares held by his spouse and includes a disclaimer of beneficial ownership by the reporting person.
Myseum, Inc. director Carly Schumer was granted options to buy 5,000 shares of the company's common stock on 08/18/2025 under the Amended and Restated 2021 Equity Incentive Plan. The options vest in four equal semiannual installments, with the first installment vesting six months after issuance, and have an exercise/ conversion timeframe showing exercisable through 08/18/2030. Following the grant, Schumer directly beneficially owns 5,000 options. The Form 4 was signed on 08/19/2025.
Form 8-K filing dated Aug 8 2025 discloses that DatChat, Inc. has filed a Certificate of Amendment with Nevada authorities to change its corporate name to Myseum, Inc.. The amendment was effected on Aug 7 2025 under NRS 78.390(8), therefore no shareholder vote was required.
- Trading symbols: Common stock will switch from DATS to MYSE; Series A warrants from DATSW to MYSEW, both effective at the opening of trading on Aug 11 2025.
- Shareholder impact: Rights, CUSIP numbers (23816M206 for common; 23816M115 for warrants) and warrant exercise terms are unchanged; holders need take no action.
- Disclosure items: Item 5.03 (Charter Amendment), Item 8.01 (press release) and Exhibit Index (3.1 Charter Amendment, 99.1 press release, 104 cover data file).
The filing is an administrative rebranding; it does not contain financial results, guidance or transactional details.